Cite
HARVARD Citation
Dejgaard, T. et al. (2015). Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes—a protocol for a randomised, double-blind, placebo-controlled study: The Lira-1 study. BMJ open. 5 (4), p. . [Online].